Six Degrees Medical – A Reverba® Company’s Post

By leveraging data, clinical expertise, and digital tools, healthcare payers and pharmaceutical companies can collaborate to improve patient journeys and treatment management in value-based care for chronic diseases. A collaborative, VBC-oriented approach using virtual care models can personalize care delivery, optimize resource allocation, and ultimately improve patient outcomes. #ValueBasedCare #Healthcare #VBC

For years, patient centricity has primarily focused on healthcare providers. Initially more of a buzzword than a practice, there's now a significant movement to actively involve patients in their care. This shift spans provider medicine, pharmaceutical R&D, and insurance payers, emphasizing personalized medicine, better treatment outcomes, and consumer experience. This blog discusses why patient centricity matters in healthcare and the role of data management in achieving its benefits. #NetApp #ONTAP #DataManagement

For years, patient centricity has primarily focused on healthcare providers. Initially more of a buzzword than a practice, there's now a significant movement to actively involve patients in their care. This shift spans provider medicine, pharmaceutical R&D, and insurance payers, emphasizing personalized medicine, better treatment outcomes, and consumer experience. This blog discusses why patient centricity matters in healthcare and the role of data management in achieving its benefits. #NetApp #ONTAP #DataManagement

Healthcare Ecosystem How can healthcare ecosystems improve healthcare? The healthcare ecosystem is a complex and ever-changing landscape. To improve healthcare, we must first understand how the ecosystem works and how we can best navigate it. The healthcare ecosystem is made up of many different stakeholders, each with their own unique goals and objectives. These stakeholders include patients, providers, payers, pharmaceutical companies, and medical device manufacturers, to name a few. To improve healthcare, we must first understand the needs of each stakeholder and how they fit into the ecosystem. For example, patients need access to affordable and high-quality care, providers need to be able to deliver care efficiently and effectively, and payers need to be able to control costs. Once we understand the needs of each stakeholder, we can begin to identify areas where the healthcare ecosystem can be improved. For example, we can improve access to care by increasing funding for primary care and increasing the number of providers. We can improve the quality of care by investing in research and development and by implementing quality improvement initiatives. And we can control costs by increasing transparency and by implementing value-based care models. There are many other ways to improve healthcare, but these are just a few examples. The important thing is to start with a clear understanding of the healthcare ecosystem and the needs of each stakeholder. Only then can we begin to identify areas where improvements can be made.

Criteria for the Value Assessment for Medication Adherence-Enhancing Interventions "To identify and critically evaluate important criteria for the value assessment of MAEIs, focus groups involving academia, pharma, payers, and healthcare practitioners (HCPs) were conducted. Participants were presented with a list of criteria identified from a previously conducted systematic literature review (SLR) to evaluate them, identify any new criteria, and rank the 10 most important criteria from their perspectives." https://lnkd.in/dAfsQspZ

Patients want access to affordable therapy. Pharma brands want patients to access their therapies. So, what’s standing in the way? Fragmentation and manual processes currently create barriers between pharma companies, providers, payers, and pharmacies. So how can we lower those barriers to help patients get therapies faster? In his latest @Drug Channels post, @Kevin Kettler explores how @CoverMyMeds helps pharma brands remove barriers to collaboration with providers, payers, and pharmacies. Read more: https://lnkd.in/ebris-Yv #NoBarriers

Patients want access to affordable therapy. Pharma brands want patients to access their therapies. So, what’s standing in the way? Fragmentation and manual processes currently create barriers between pharma companies, providers, payers, and pharmacies. So how can we lower those barriers to help patients get therapies faster? In his latest @Drug Channels post, @Kevin Kettler explores how @CoverMyMeds helps pharma brands remove barriers to collaboration with providers, payers, and pharmacies. Read more: https://lnkd.in/e2Wq8yci #NoBarriers

Enabling Deeper Medication Adherence Insights to Guide Us towards Better Healthcare Experiences https://lnkd.in/guZv3RQg PatchRx Andrew Aertker Harris Healthcare DrFirst, Inc. #HealthcareAnalytics, #PatientManagement, #PatientEngagement, #MedicationManagement, #MedicationAdherence, #DataManagement, #Healthcare, #Medical, #DigitalHealthcareTransformation, #Pharmaceuticals, #CareManagement

Patient support programs play a crucial role in helping individuals manage their conditions and adhere to treatment regimens. Despite investing over $5.7 billion (about $18 per person in the US) by the pharmaceutical industry in patient support programs, the utilization of these programs remains lower than 5%. To better understand the dynamics at play, Phreesia conducted a comprehensive survey to assess patient awareness, usage, and perceptions of support programs. The survey included 4,869 participants, with a majority under 65 years old (69%) and female (65%). Notably, 69% of respondents were on medication, reflecting a relevant sample for evaluating patient support programs. Key findings include: ·      Patient Needs: 79% of patients who value support programs found specific ones helpful. ·      Low Usage and Familiarity: Only 8% of patients reported having used such programs, and a mere 3% were currently using them. This low utilization can be attributed to a significant lack of familiarity: 59% of patients had little to no knowledge of these programs. ·       Usage Patterns: Patients typically engage with these resources during key moments in their treatment journey, such as starting a new medication, receiving a first diagnosis, or switching medications. However, 61% of patients do not perceive much value in these programs, suggesting that existing support services may not fully meet patient needs or expectations. ·      Desired Support Services: Patients expressed a desire for more support, particularly in areas such as medication adherence, emotional support, and educational resources. ·      Awareness Channels: There is a significant opportunity to expand and optimize the channels through which patients learn about support programs. While 44% of patients learned about support programs online, a majority (55%) still preferred to receive this information from their doctors. The lack of awareness and underutilization of patient support programs highlights the urgent need for improved efforts from healthcare providers and pharmaceutical companies. Tailored marketing campaigns, integrated omnichannel plans, and enhanced online experiences can significantly increase awareness and access to these programs. Also, partnering with pharmacies for educational outreach and expanding support services for continuous patient assistance can enhance these initiatives' effectiveness. #Pharmaceuticals #Healthcare #PatientCentricity #PatientEngagement #PatientProgram

Patients want access to affordable therapy. Pharma brands want patients to access their therapies. So, what’s standing in the way? Fragmentation and manual processes currently create barriers between pharma companies, providers, payers, and pharmacies. So how can we lower those barriers to help patients get therapies faster? In his latest @Drug Channels post, @Kevin Kettler explores how @CoverMyMeds helps pharma brands remove barriers to collaboration with providers, payers, and pharmacies. Read more: https://lnkd.in/eXgypZ2V #NoBarriers